Buying prescription drugs online: a dangerous shortcut

The black market for online medicines: when lack of access pushes people to take risks

Every year, the Spanish Agency for Medicines and Health Products (AEMPS) seizes tons of counterfeit drugs from online sales without a prescription. Yet demand does not stop. The latest stop: a German pharmacy that, combined with an intermediary company, allows people in Spain to receive medicines that require a prescription. The operation is simple: you search for the drug on foreign portals, pay, and a forwarding service puts it in your mailbox. The problem is that what is legal in one country is not always safe, and what is safe is rarely sold without a prescription.

Blurred borders between need and crime

In Spain, the dispensing of prescription medicines is regulated by the Law on Guarantees and Rational Use. Buying them without a prescription, even from an online pharmacy in another EU country, is illegal. However, some argue that the slowness of the health system or the lack of access to certain treatments (such as drugs for erectile dysfunction, anxiolytics or antibiotics) pushes people to look for alternatives. At the other extreme, those who warn: buying minoxidil is not the same as buying fentanyl, oxycodone or Rivotril, drugs with high potential for abuse and counterfeiting.

Risks that go beyond legality

The main danger is not that the police intercept it, but that the medicine you receive is fake, incorrectly dosed or expired. The World Health Organization estimates that 50% of medicines sold on the internet without a prescription are fake. In the specific case of the German pharmacy shop-apotheke.com, it is a legitimate portal, but shipping to Spain requires an intermediary company that evades customs controls. That opens the door to impersonations and altered products.

The dilemma of controlled accessibility

Behind these searches are real people with health problems who do not find answers from their doctor or local pharmacy. The easy answer is to incivil the user; the complex one is to understand why they break the rule. As long as health systems do not guarantee fast and affordable access, the gray market will continue to exist. The question that remains is: where to draw the line between accessibility and safety? Authorities are tightening controls, but detecting every shipment is like finding a needle in a digital haystack.